AKT2 Blocking Peptide (N-term)

Produktübersicht

• Artikelname: AKT2 Blocking Peptide (N-term)
• Artikelnummer: ABT-BP7029A
• Hersteller Artikelnummer: BP7029a
• Alternativnummer: ABT-BP7029A-500UG
• Hersteller: Abcepta
• Kategorie: Proteine/Peptide
• Alternative Synonym: RAC-beta serine/threonine-protein kinase, Protein kinase Akt-2, Protein kinase B beta, PKB beta, RAC-PK-beta, AKT2

Produktbeschreibung

AKT2 is a putative oncogene encoding a protein belonging to a subfamily of serine/threonine kinases containing SH2-like (Src homology 2-like) domains. Furthermore, AKT2 was shown to be amplified and overexpressed in 2 of 8 ovarian carcinoma cell lines and 2 of 15 primary ovarian tumors. Overexpression of AKT2 contributes to the malignant phenotype of a subset of human ductal pancreatic cancers. AKT2 is a general protein kinase capable of phophorylating several known proteins.

Produkteigenschaften

• NCBI: 208
• UniProt: P31751
• Formulierung: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
• Target-Kategorie: The synthetic peptide sequence is selected from aa 108-123 of HUMAN AKT2